Sporadic multiple primary melanoma cases:CDKN2Agermline mutations with a founder effect (Q56893701)

12

Brigitte Bressac-de Paillerets

0 references

Marie-Françoise Avril

2

Marie-Françoise Avril

0 references

Alisa M. Goldstein

5

Alisa M. Goldstein

0 references

Giovanna Bianchi-Scarrà

6

Giovanna Bianchi-Scarrà

0 references

Agnès Chompret

3

Agnès Chompret

0 references

Alain Spatz

9

Alain Spatz

0 references

author name string

Stéphane Auroy

1

0 references

Danièle Pham

4

0 references

Thierry Frebourg

7

0 references

Pascal Joly

8

0 references

Carole Rubino

Genes, Chromosomes and Cancer

10

0 references

publication date

28 August 2001

0 references

language of work or name

English

0 references

published in

0 references

volume

32

0 references

issue

3

0 references

page(s)

195-202

0 references

cites work

Point mutations can inactivate in vitro and in vivo activities of p16(INK4a)/CDKN2A in human glioma

1 reference

Tumor Suppressor p16INK4A: Determination of Solution Structure and Analyses of Its Interaction with Cyclin-Dependent Kinase 4

21 January 2018

1 reference

A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families

21 January 2018

1 reference

Germline p16 mutations in familial melanoma

21 January 2018

1 reference

A cell cycle regulator potentially involved in genesis of many tumor types

21 January 2018

1 reference

Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus

21 January 2018

1 reference

Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition

21 January 2018

1 reference

Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma

21 January 2018

1 reference

CDKN2A Germline Mutations in U.K. Patients with Familial Melanoma and Multiple Primary Melanomas

21 January 2018

1 reference

Control of pRB phosphorylation

21 January 2018

1 reference

Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors

21 January 2018

1 reference

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

21 January 2018

1 reference

Temperature-sensitive mutants of p16CDKN2 associated with familial melanoma

21 January 2018

1 reference

Functional evaluation of tumour-specific variants of p16INK4a/CDKN2A: correlation with protein structure information

21 January 2018

1 reference

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

21 January 2018

1 reference

Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]

21 January 2018

1 reference

Tumor suppressor p16INK4A: structural characterization of wild-type and mutant proteins by NMR and circular dichroism

21 January 2018

1 reference

Functional reassessment of P16 variants using a transfection-based assay

21 January 2018

1 reference

A Familial Syndrome of Pancreatic Cancer and Melanoma with a Mutation in theCDKN2Tumor-Suppressor Gene

21 January 2018

1 reference

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma

21 January 2018

1 reference

Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16

21 January 2018

1 reference

Genetic aspects of malignant melanoma

21 January 2018

1 reference

7 January 2021

Characterization of ligurian melanoma families and risk of occurrence of other neoplasia

1 reference

7 January 2021

Mutations in the CDKN2A ( p16INK4a ) gene in microdissected sporadic primary melanomas

1 reference

7 January 2021

Loss of heterozygosity at chromosome 9p21 (INK4-p14ARF locus): homozygous deletions and mutations in the p16 and p14ARF genes in sporadic primary melanomas

1 reference

7 January 2021

CDKN2AMutations in Multiple Primary Melanomas

1 reference

7 January 2021

p16/CDKN2 andCDK4 gene mutations in sporadic melanoma development and progression

1 reference

7 January 2021

Haplotype analysis of two recurrent CDKN2A mutations in 10 melanoma families: evidence for common founders and independent mutations

1 reference

7 January 2021